| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |